1,053 Companies

Access all companies

Find technology partners quickly.

Spotfolio tracks over one million companies in technology industries.

There are 1,053 companies in the field of Biopharma on spotfolio that produce or deliver products, that utilize or research technologies or that are otherwise engaged in topics such as Clinical, Drug, Biotechnology, Research, Therapeutic, Scientific, Disease, University .

Start-ups (139)

Early-stage companies (300)

Established companies (540)

The majority of these companies is located in the following countries.

United States (525)

United Kingdom (78)

Canada (55)

China (53)

Example Companies

Find companies in your area

Cellect Biotechnology Cellect Biotechnology Ltd

established

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

News April 3, 2020 Cellect Biotechnology Reports Fourth Quarter and Full Year 2019 Results April 2, 2020 Cellect Biotechnology Receives New Patent Allowance ...

Allowance in China March 4, 2020 Cellect Biotechnology and Canndoc Ltd. to Enter Into Strategic Pharma Grade Cannabis Commercial Deal for Reduction in Opioid ...

2020 Cellect Biotechnology Ltd. Prices $3m Registered Direct Offering of American Depositary Shares January 7, 2020 Cellect Biotechnology Strengthens IP ...

December 23, 2019 Cellect Biotechnology Receives Approval for U.S. Clinical Trial November 19, 2019 Cellect Biotechnology Reports Third Quarter 2019 ...

November 7, 2019 Cellect Biotechnology Regains Compliance With Nasdaq Minimum Bid Price Requirement August 12, 2019 Cellect Biotechnology Announces Positive ...

Successfully Transplants 9th Clinical Trial Patient July 9, 2019 Cellect Biotechnology and Washington University (WU) Finalize Accelerated Clinical Trial Agreement

Yarkoni has also been the Chief Executive Officer and Chairman of GASR Biotechnology, a life science consulting firm. From 2009 until 2013, Dr. Yarkoni served ...

Officer and a director of BioNegev, an international innovation centre for biotechnology and life sciences in the Negev region. Prior to that he served as Chief ...

Collgard Biopharmaceutical, a tissue therapeutics company, Before moving to Biotechnology industry, Dr. Yarkoni was an attending OB/GYN specialist practicing for

Felix Biotechnology Felix Biotechnology Inc.

start-up

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

/search Felix Biotechnology mailto:info@felixbt.com Felix Biotechnology Novel solution for Infectious disease Scroll Patients can’t wait. Felix is

/search Felix Biotechnology mailto:info@felixbt.com Felix Biotechnology Novel solution for Infectious disease YC startup Felix wants to replace antibiotics ...

phage to fight the scourge of antibiotic resistant infections. Felix Biotechnology – Antibiotic Resistance—Combating This Growing Medical Problem Jan 27 ...

Blavatnik Fund awards for the promise of his research. His startup, Felix Biotechnology, is turning phage discoveries into therapies for antibiotic-resistant ...

Falling Walls Science Start-Up of the Year 2019: Felix Biotechnology Nov 13, 2019. Felix Biotechnology has won the Falling Walls Venture competition, named ...

tech platforms building tomorrow’s breakthroughs Oct 8, 2019. Felix Biotechnology, in collaboration with researchers from Yale University and UC Berkeley

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Distributors - Patient Resources - News & Media Press Releases NextSource Biotechnology Gains FDA Approval for Use of Tradename Gleostine™ (Lomustine), an Anti-Cancer ...

Former Drug Name CeeNu® MIAMI, Aug. 7, 2014 /PRNewswire/ -- NextSource Biotechnology (NSB) is a leading specialty pharmaceutical manufacturer with a focus ...

unnecessary risk to both healthcare providers and patients. NextSource Biotechnology is committed to providing the highest quality product with a consistent ...

re-branding of Gleostine®," said Robert DiCrisci, President, CEO of NextSource Biotechnology, "is the first of many product launches to come. As this initiative continues ...

with critical medical need." About NextSource Biotechnology: Established in 2010, NextSource Biotechnology is a leading specialty pharmaceutical manufacturer ...

is an expert contract manufacturer helping leading pharmaceutical and Biotechnology companies link their requirements for product success with their patients'

with initial chemotherapy... Read more Our Press Releases NextSource Biotechnology Gains FDA Approval For New 5 Mg Strength Of Gleostine® (Lomustine), An ...

Chemotherapy Agent ... MIAMI, Jan. 20, 2016 /PRNewswire/ -- NextSource Biotechnology, LLC announced today that Gleostine® (lomustine) 5 mg capsules has been ...

the United States. Gleostine® is approved... Read more NextSource Biotechnology Gains FDA Approval for Use of Tradename Gleostine® (Lomustine), an Anti-Cancer ...

Chemotherapy Agent... MIAMI, Aug. 7, 2014 /PRNewswire/ -- NextSource Biotechnology (NSB) is a leading specialty pharmaceutical manufacturer with a focus ...

product name change from Lomustine (CCNU)... Read more NextSource Biotechnology Announces FDA Short Supply release of the formally known Bristol Myers ...

(CeeNu®) Brand Oncology product ... MIAMI, Jan. 24, 2014 -- NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing

Marx Biotechnology

established

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

- Team - Vision - News - Contact Select Page Our Vision Marx Biotechnology is looking to build a stand along company both diagnostic and pharmaceutical ...

to market, then utilize that income to grow the company. Once Marx Biotechnology has the full prototype and a product on the market, our vision is to ...

continuing therapeutic development. 1 Year Plan Within the next year Marx Biotechnology (MBT) will have its first patent issued (US, EU and IL), an initial prototype ...

(GVHD) and for preeclampsia (PE) IP is essential for the biotechnology industry. Marx Biotechnology (MBT) has two patents that are in the final stages.MBT

program under grant agreement No 877774 Nov 5, 2019 | General Marx Biotechnology was awarded and has received funding from the European Union’s Horizon

Vir Biotechnology Vir Biotechnology, Inc.

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Title 11/10/20 Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2020 Financial Results 11/6/20 Vir Biotechnology Publishes New Research ...

10/27/20 Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2020 Financial Results on November 10, 2020 10/21/20 Vir Biotechnology Presents ...

Virus Mini-Conference 10/9/20 Nature Publishes New Research from Vir Biotechnology Demonstrating the Capacity of Enhanced Monoclonal Antibodies to Induce ...

Induce Protective Adaptive Immunity to Viral Infection 10/6/20 Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating ...

9/24/20 Vir Biotechnology Publishes New Research Characterizing Antibody Response to SARS-CoV-2 in the Journal Cell 9/9/20 Vir Biotechnology to Present ...

Present at Cantor Global Virtual Healthcare Conference 9/8/20 Vir Biotechnology to Present at H.C. Wainwright 22nd Annual Global Investment Conference Pagination

Vir Biotechnology to Present at H.C. Wainwright 22nd Annual Global Investment Conference September 8, 2020 SAN FRANCISCO, Sept. 08, 2020 (GLOBE NEWSWIRE) ...

NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today ...

archived there following the presentation for 30 days. About Vir Biotechnology Vir Biotechnology is a clinical-stage immunology company focused on combining ...

virus and tuberculosis. For more information, please visit Contact: Vir Biotechnology, Inc. Investors Neera Ravindran, MD VP, Head of Investor Relations & ...

Normart W2O Group jnormart@w2ogroup.com +1-559-974-3245 Source: Vir Biotechnology, Inc.

Use detailed technology terms.

Only spotfolio allows for searching with detailed technology terms, as we provide you with all topics that technology companies talk about.

Use Cases

Register now

Why Technology Scouting?

Technology scouting is the basis for your innovation management, identifies new technological developments as early as possible and protects you from disruptive business models.

Identify technology partners

Boost your market research

Look beyond major players

Build long and short lists

Collect technology leaders, providers, start ups and potential new partners in lists via simple tagging to take further steps with your team.